Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 139
Filter
1.
Hernia ; 27(2): 273-279, 2023 04.
Article in English | MEDLINE | ID: mdl-35312890

ABSTRACT

PURPOSE: Patient optimization and selecting the proper technique to repair large incisional hernias is a multifaceted challenge. Body mass index (BMI) is a modifiable variable that may infer higher intra-abdominal pressures and, thus, predict the need for component separation (CS) at the time of surgery, but no data exist to support this. This paper assesses if the ratio of anterior-posterior (AP): transverse (TRSV) abdominal diameter, from pre-operative CT imaging, indicates a larger proportion of intra-abdominal fat and correlates with a hernia defect requiring a component separation for successful tension-free closure. METHODS: Ninety patients were identified who underwent either an open hernia repair with mesh by primary closure (N = 53) or who required a component separation at the time of surgery (N = 37). Pre-operative CT images were used to measure hernia defect width, AP abdominal diameter, and TRSV abdominal diameter. Quantitative data, nominal data, and logistic regression was used to determine predictors associated with surgical group categorization. RESULTS: The average hernia defect widths for primary closure and CS were 7.7 ± 3.6 cm (mean ± SD) and 9.8 ± 4.5, respectively (p = 0.015). The average BMI for primary closure was 33.9 ± 7.2 and 33.8 ± 4.9 for those requiring CS (p = 0.924). The AP:TRSV diameter ratios for primary closure and CS were 0.41 ± 0.08 and 0.49 ± 0.10, respectively (p < 0.001). In a multivariate analysis including both defect width and AP:TRSV diameter ratio, only AP:TRSV diameter ratio predicted the need for a CS (p = 0.001) while BMI did not (p = 0.92). CONCLUSION: Intraabdominal fat distribution measured by AP:TRSV abdominal diameter ratio correlates with successful tension-free fascial closure during incisional hernia repair, while BMI does not.


Subject(s)
Abdominal Wall , Hernia, Ventral , Incisional Hernia , Humans , Abdominal Wall/surgery , Body Mass Index , Herniorrhaphy/methods , Surgical Mesh , Hernia, Ventral/surgery , Incisional Hernia/surgery
2.
Am J Physiol Regul Integr Comp Physiol ; 313(3): R290-R297, 2017 Sep 01.
Article in English | MEDLINE | ID: mdl-28701320

ABSTRACT

Radiation exposure accelerates the onset of age-related diseases such as diabetes, cardiovascular disease, and neoplasia and, thus, lends insight into in vivo mechanisms common to these disorders. Fibrosis and extracellular matrix (ECM) remodeling, which occur with aging and overnutrition and following irradiation, are risk factors for development of type 2 diabetes mellitus. We previously demonstrated an increased incidence of skeletal muscle insulin resistance and type 2 diabetes mellitus in monkeys that had been exposed to whole body irradiation 5-9 yr prior. We hypothesized that irradiation-induced fibrosis alters muscle architecture, predisposing irradiated animals to insulin resistance and overt diabetes. Rhesus macaques (Macaca mulatta, n = 7-8/group) grouped as nonirradiated age-matched controls (Non-Rad-CTL), irradiated nondiabetic monkeys (Rad-CTL), and irradiated monkeys that subsequently developed diabetes (Rad-DM) were compared. Prior radiation exposure resulted in persistent skeletal muscle ECM changes, including a relative overabundance of collagen IV and a trend toward increased transforming growth factor-ß1. Preservation of microvascular markers differentiated the irradiated diabetic and nondiabetic groups. Microvascular density and plasma nitrate and heat shock protein 90 levels were lower in Rad-DM than Rad-CTL. These results are consistent with a protective effect of abundant microvasculature in maintaining glycemic control within radiation-induced fibrotic muscle.


Subject(s)
Diabetes Mellitus, Type 2/physiopathology , Extracellular Matrix/pathology , Insulin Resistance/radiation effects , Microvessels/pathology , Microvessels/radiation effects , Muscle, Skeletal/pathology , Radiation Exposure/adverse effects , Animals , Diabetes Mellitus, Type 2/etiology , Diabetes Mellitus, Type 2/pathology , Dose-Response Relationship, Radiation , Extracellular Matrix/radiation effects , Female , Macaca mulatta , Male , Muscle, Skeletal/radiation effects , Radiation Dosage , Radiation Injuries/etiology , Radiation Injuries/pathology , Radiation Injuries/physiopathology , Reactive Oxygen Species
3.
J Nutr Health Aging ; 21(4): 354-361, 2017.
Article in English | MEDLINE | ID: mdl-28346561

ABSTRACT

OBJECTIVE: We aimed to examine the general health and intestinal physiology of young and old non-human primates with comparable life histories and dietary environments. DESIGN: Vervet monkeys (Chlorcebus aethiops sabaeus) in stable and comparable social and nutritional environments were selected for evaluation. Health phenotype, circulating cytokines and biomarkers of microbial translocation (MT) were measured (n=26-44). Subsets of monkeys additionally had their intestinal motility, intestinal permeability, and fecal microbiomes characterized. These outcomes document age-related intestinal changes present in the absence of nutritional stressors, which are all known to affect gastrointestinal motility, microbiome, and MT. RESULTS: We found that old monkeys have greater systemic inflammation and poor intestinal barrier function as compared to young monkeys. Old monkeys have dramatically reduced intestinal motility, and all changes in motility and MT are present without large differences in fecal microbiomes. CONCLUSION: We conclude that deteriorating intestinal function is a feature of normal aging and could represent the source of inflammatory burden yet to be explained by disease or diet in normal aging human primate populations. Intestinal changes were seen independent of dietary influences and aging within a consistent environment appears to avoid major microbiome shifts. Our data suggests interventions to promote intestinal motility and mucosal barrier function have the potential to support better health with aging.


Subject(s)
Aging/physiology , Chlorocebus aethiops/physiology , Gastrointestinal Microbiome , Gastrointestinal Motility/physiology , Inflammation/physiopathology , Intestinal Mucosa/physiology , Tight Junctions/physiology , Animals , Biomarkers/blood , Cytokines/blood , Diet , Female , Humans , Male
4.
Dentomaxillofac Radiol ; 44(2): 20140223, 2015.
Article in English | MEDLINE | ID: mdl-25352427

ABSTRACT

OBJECTIVES: The aim of this work was to estimate the doses to radiosensitive organs in the head of a young child undergoing panoramic radiography and to establish the effectiveness of a short collimator in reducing dose. METHODS: Thermoluminescent dosemeters were used in a paediatric head phantom to simulate an examination on a 5-year-old child. The panoramic system used was an Instrumentarium OP200 D (Instrumentarium Dental, Tuusula, Finland). The collimator height options were 110 and 140 mm. Organ doses were measured using exposure programmes intended for use with adult and child size heads. The performance of the automatic exposure control (AEC) system was also assessed. RESULTS: The short collimator reduced the dose to the brain and the eyes by 57% and 41%, respectively. The dose to the submandibular and sublingual glands increased by 32% and 20%, respectively, when using a programme with a narrower focal trough intended for a small jaw. The effective dose measured with the short collimator and paediatric programme was 7.7 µSv. The dose to the lens of the eye was 17 µGy. When used, the AEC system produced some asymmetry in the dose distribution across the head. CONCLUSIONS: Panoramic systems when used to frequently image children should have programmes specifically designed for imaging small heads. There should be a shorter collimator available and programmes that deliver a reduced exposure time and allow reduction of tube current. Programme selection should also provide flexibility for focal trough size, shape and position to match the smaller head size.


Subject(s)
Head/radiation effects , Phantoms, Imaging , Radiation Dosage , Radiation Protection/standards , Radiography, Panoramic/instrumentation , Brain/radiation effects , Child, Preschool , Equipment Design , Eye/radiation effects , Humans , Radiation Injuries/prevention & control , Salivary Glands/radiation effects
5.
Br J Radiol ; 86(1027): 20130053, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23652542

ABSTRACT

In the emergency department, patients undergoing lateral lumbar spine radiography examinations are positioned either lying on their side on an X-ray table with the X-ray beam vertical or lying supine on a trolley with the X-ray beam horizontal. The measured dose-area product (DAP) values were found to differ significantly, typically 1.3 Gy cm(2) for those patients examined on the X-ray table and 2.7 Gy cm(2) for those on a trolley. This work investigates the reason for higher DAP values with the horizontal beam technique. The UK's current recommended national diagnostic reference level (NDRL) for the lateral lumbar spine is 2.5 Gy cm(2). The measurements of body diameter on volunteers showed that rotating the patients from their side to their back resulted in an increase in tissue thickness of between 2 cm and 9 cm for the lumbar region. X-ray absorption increases exponentially with increasing tissue thickness. An increase of 5 cm in body diameter for a lateral lumbar spine at 93 kV will increase the DAP by more than two-fold. Mathematical modelling and measurements with polymethyl methacrylate provided data to predict the tube potential increase necessary to reduce the DAP. For the horizontal beam technique, the tube potential was increased from 93 kV to 102 kV and the average DAP reduced to 2.3 Gy cm(2). Radiographic technique should be understood when auditing the dose. Tube potential must be increased to optimise the horizontal beam technique. The 2.5-Gy cm(2) NDRL relates predominantly to the more common vertical beam technique. Separate local diagnostic reference levels for horizontal and vertical beam techniques are recommended.


Subject(s)
Lumbar Vertebrae/diagnostic imaging , Models, Theoretical , Patient Positioning/adverse effects , Radiation Dosage , Radiography/methods , Humans , Patient Positioning/methods , Polymethyl Methacrylate , Radiation Monitoring , Radiography/adverse effects , Supine Position
6.
Clin Nutr ; 23(1): 27-34, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14757390

ABSTRACT

Carnitine metabolism and the therapeutic use of carnitine has been a major area of interest in dialysis patients. The purpose of this study was to determine whether any correlations exist between carnitine status and selected clinical parameters in hemodialysis (HD) patients. This study was an observational study of data from patients receiving HD at a Midwest dialysis center. The subjects (n=49) were 60+/-16 (mean+/-SD) years of age and 48% male. Fifteen percent of the subjects had type 1 diabetes mellitus (DM), 29% had type 2 DM, and 25% had left ventricular hypertrophy (LVH). The serum-free and total carnitine, and acylcarnitine concentrations were: 40.3+11.8 microm/l, 22.8+/-7.3, and 17.5+/-5.9 microm/l, respectively. The serum acylcarnitine to free carnitine ratio (A/F) was 0.80+/-0.27. Blood urea nitrogen (BUN), parathyroid hormone and ejection fraction were positively correlated and age and left atrial dilation (cm) were negatively correlated with serum total carnitine (P<0.05). BUN and hematocrit were positively correlated (P<0.05) and age was negatively correlated with free carnitine. Subjects who used mannitol or were male had significantly higher concentrations of both free and total carnitine, respectively (P<0.05). Subjects using aspirin had lower concentrations of serum total carnitine (P<0.10). These results suggest certain subgroups of patients may need to be targeted for further studies with carnitine replacement therapy, i.e. long-term patients, older patients, patients with left verticular hypertrophy and left atrial enlargement, females and patients on aspirin therapy.


Subject(s)
Carnitine/analogs & derivatives , Carnitine/blood , Kidney Failure, Chronic/blood , Renal Dialysis , Age Factors , Blood Urea Nitrogen , Carnitine/metabolism , Carnitine/therapeutic use , Diabetes Complications , Diabetes Mellitus/therapy , Female , Humans , Kidney Failure, Chronic/complications , Kidney Failure, Chronic/therapy , Male , Mannitol/administration & dosage , Middle Aged , Parathyroid Hormone/blood , Treatment Outcome , Ventricular Dysfunction, Left/complications , Ventricular Dysfunction, Left/therapy
7.
Curr Cancer Drug Targets ; 4(1): 77-84, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14965269

ABSTRACT

Recent studies have generated sufficient information to warrant a consideration of protein kinase CK2 as a potential target for cancer therapy. CK2 is a ubiquitous and highly conserved protein serine/threonine kinase that has long been considered to play a role in cell growth and proliferation. It is essential for cell survival, and considerable evidence suggests that it can also exert potent suppression of apoptosis in cells. This is important since the cancer phenotype is characterized by deregulation of not only proliferation but also of apoptosis. In normal cells, the level of CK2 appears to be tightly regulated, and cells resist a change in their intrinsic level of CK2. However, in all the cancers that have been examined an elevation of CK2 has been observed. Further, it appears that modest deregulation in the CK2 expression imparts a potent oncogenic potential to the cells. Disruption of CK2 by treatment of cells with antisense CK2 results in induction of apoptosis in a time and dose-dependent manner. Thus, we propose that down-regulation of CK2 by employing specific strategies to deliver antisense CK2 in vivo could have a potential role in cancer therapy.


Subject(s)
DNA-Binding Proteins/metabolism , Neoplasms/therapy , Protein Serine-Threonine Kinases/metabolism , Animals , Casein Kinase II , Cell Survival/physiology , DNA-Binding Proteins/antagonists & inhibitors , Down-Regulation , Enzyme Inhibitors/pharmacology , Humans , Neoplasms/enzymology , Protein Serine-Threonine Kinases/antagonists & inhibitors
8.
J Burn Care Rehabil ; 24(5): 318-21; discussion 317, 2003.
Article in English | MEDLINE | ID: mdl-14501403

ABSTRACT

Nationally, approximately 10% of child abuse cases involve burning, and up to 20% of pediatric burn admissions involve abuse or neglect. Historically, these cases have been more difficult to prosecute than nonburn cases for multiple reasons. Between 1995 and 1999, there were 285 pediatric (under 18) patients admitted to the Spectrum Health Regional Burn Center. Of these cases, 18 of the alleged perpetrators were legally investigated for suspicion of child abuse, and 7 received punitive sentences. We found that men tended to be prosecuted and convicted more often than women and that cases involving multiple instances of injury tended to be prosecuted more frequently. Similarly, we found that cases involving more severe injuries tended to be prosecuted more successfully. There are many psychological and social factors involved in handling burn abuse cases. However, by successful prosecution of these crimes, victims tend to fare better both socially and psychologically.


Subject(s)
Burns/classification , Burns/epidemiology , Child Abuse/legislation & jurisprudence , Child Abuse/statistics & numerical data , Adolescent , Age Distribution , Burn Units/statistics & numerical data , Child , Child, Preschool , Comorbidity , Female , Humans , Infant , Law Enforcement , Male , Retrospective Studies , Sex Distribution , United States/epidemiology
9.
Gynecol Oncol ; 80(3): 350-4, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11263930

ABSTRACT

OBJECTIVES: The incidence of cervical dysplasia and carcinoma is known to be increased in HIV-infected women. In addition, there is a positive correlation between HIV viral load (VL), CD4+ count, and opportunistic infections, as well as the incidence of various malignancies. This study compares HIV VL and CD4+ count with the presence of cervical dysplasia, as well as with the degree of severity of dysplasia. METHODS: A retrospective chart review of 350 HIV-infected women with polymerase chain reaction (PCR) quantitation of viral load was performed to identify 82 women with biopsy-proven cervical dysplasia and 25 women without any significant cervical pathology. The highest plasma VL within a year of the patients' cervical pathology and corresponding CD4+ count was selected and compared with cervical pathology. Univariate and multivariate statistical analysis using Student's t test and logistic regression analysis was used to analyze the significance of other risk factors such as age, race, smoking history, history of illicit drug use, and prior sexually transmitted disease as well as of viral load and CD4+ count. RESULTS: Of 82 cases of cervical dysplasia, 33 (40.24%) were mild (CIN I), 47 (57.32%) were either moderate or severe (CIN II-III) dysplasia, and 2 demonstrated invasive squamous cell carcinoma (2.44%). A significant statistical difference was found when comparing either HIV plasma VL or CD4+ T-cell counts with the presence of cervical dysplasia on biopsy (P < 0.005). However, only CD4+ count was identified as an independent risk factor for the presence of cervical dysplasia after multivariate analysis. CONCLUSION: In our population, there is a significant correlation between VL and CD4+ count and the presence of cervical dysplasia. However, VL does not appear to be an independent risk factor for cervical dysplasia in this population of HIV-infected women.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , Carcinoma, Squamous Cell/virology , HIV Infections/blood , HIV Infections/immunology , HIV , Uterine Cervical Dysplasia/virology , Uterine Cervical Neoplasms/virology , Adolescent , Adult , Aged , CD4 Lymphocyte Count , CD4-Positive T-Lymphocytes/cytology , Carcinoma, Squamous Cell/blood , Carcinoma, Squamous Cell/immunology , Female , HIV/genetics , HIV Infections/complications , Humans , Middle Aged , Multivariate Analysis , RNA, Viral/blood , Regression Analysis , Retrospective Studies , Uterine Cervical Dysplasia/blood , Uterine Cervical Dysplasia/immunology , Uterine Cervical Neoplasms/blood , Uterine Cervical Neoplasms/immunology , Viral Load
10.
J Biol Chem ; 276(8): 5992-9, 2001 Feb 23.
Article in English | MEDLINE | ID: mdl-11069898

ABSTRACT

Protein kinase CK2 (CK2) has long been implicated in the regulation of cell growth and proliferation. Its activity is generally elevated in rapidly proliferating tissues, and nuclear matrix (NM) is an important subnuclear locale of its functional signaling. In the prostate, nuclear CK2 is rapidly lost commensurate with induction of receptor-mediated apoptosis after growth stimulus withdrawal. By contrast, chemical-induced apoptosis in prostate cancer and other cells (by etoposide and diethylstilbestrol) evokes an enhancement in CK2 associated with the NM that appears to be because of translocation of CK2 from the cytoplasmic to the nuclear compartment. This shuttling of CK2 to the NM may reflect a protective response to chemical-mediated apoptosis. Supporting evidence for this was obtained by employing cells that were transiently transfected with various expression plasmids of CK2 (thereby expressing additional CK2) prior to treatment with etoposide or diethylstilbestrol. Cells transfected with the CK2alpha or CK2alphabeta showed significant resistance to chemical-mediated apoptosis commensurate with the corresponding elevation in CK2 in the NM. Transfection with CK2beta did not demonstrate this effect. These results suggest, for the first time, that besides the commonly appreciated function of CK2 in cell growth, it may also have a role in protecting cells against apoptosis.


Subject(s)
Apoptosis , Nuclear Matrix/enzymology , Protein Serine-Threonine Kinases/metabolism , Adenocarcinoma/drug therapy , Animals , Casein Kinase II , Catalytic Domain , Cell Compartmentation , Cytoprotection , Cytosol/enzymology , DNA, Neoplasm/analysis , Diethylstilbestrol/pharmacology , Etoposide/pharmacology , Female , Humans , Male , Mammary Neoplasms, Animal/drug therapy , Mice , Prostatic Neoplasms/drug therapy , Protein Serine-Threonine Kinases/genetics , Protein Transport , Recombinant Proteins/metabolism , Subcellular Fractions/enzymology
11.
Brain Behav Immun ; 14(3): 185-97, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10970679

ABSTRACT

Studies of pituitary-deficient dwarf mice show that in the absence of a normally functioning pituitary, thymus development is impaired. Treatment with growth hormone, prolactin, and thyroid hormones restores thymus development. Smaller thymus size in pituitary-deficient animals could be due to defective development of precursors, impaired precursor immigration, impaired thymocyte expansion, or development of a smaller epithelial/stromal compartment in the thymus of pituitary-deficient animals. Using a well-characterized amphibian model to study stem cell immigration into the thymus, we show here that hypophysectomy (hypx) of young tadpoles interferes with overall growth of the frogs and with the broad lymphocyte expansion that occurs after metamorphosis, but it does not interfere with the immigration of T cell precursors into an implanted thymus. Diploid host cells moving into a triploid thymus implant do so at the same rate and to the same extent in hypx hosts as they do in intact control hosts. Analysis of cell division in the implanted thymus populations shows a significantly greater proportion of cells arrested in the G(0)/G(1) phase and a significantly lower proportion of cells in the S phase and G(2) + M phase of the cell cycle in hypx hosts than in intact hosts. Thus, smaller thymus size in hypx hosts could be due to a slower rate of expansion of precursors that migrate there.


Subject(s)
Aging/physiology , Animals, Newborn/physiology , Metamorphosis, Biological/physiology , Pituitary Gland/physiology , T-Lymphocytes/cytology , Xenopus laevis/physiology , Animals , Animals, Newborn/growth & development , Cell Division/physiology , Hypophysectomy , Lymphocytes/cytology , Spleen/cytology , Thymus Gland/cytology , Thymus Gland/growth & development , Time Factors , Xenopus laevis/growth & development
12.
Head Neck ; 22(4): 341-6, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10862016

ABSTRACT

BACKGROUND: Human squamous cell carcinomas of the head and neck (SCCHN) overexpress the protein kinase CK2, and elevated CK2 activity correlates with aggressive tumor behavior and poor clinical outcome. We therefore investigated whether interference with CK2 expression would inhibit SCCHN cell growth in vitro. METHODS: We targeted the catalytic (alpha) subunit of CK2 using an antisense oligodeoxynucleotide (ODN) strategy. Human Ca9-22 cells derived from SCCHN were transfected with CK2-alpha sense, nonsense, or antisense ODN; CK2 activity was measured; and the effect on CK2 activity and on cell growth was determined. RESULTS: Transfection of Ca9-22 cells with antisense CK2-alpha ODN resulted in significantly decreased CK2 kinase activity associated with nuclear chromatin and in dose-dependent growth inhibition of Ca9-22 cells in vitro. CONCLUSIONS: Interference with the protein kinase CK2 signal in SCCHN cells may offer a novel anticancer strategy for this malignancy.


Subject(s)
Carcinoma, Squamous Cell/enzymology , Head and Neck Neoplasms/enzymology , Oligonucleotides, Antisense/pharmacology , Protein Serine-Threonine Kinases/antagonists & inhibitors , Base Sequence , Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/therapy , Casein Kinase II , Cell Division/drug effects , Cell Division/genetics , Codon, Nonsense , Dose-Response Relationship, Drug , Down-Regulation , Gene Expression/drug effects , Gene Expression/genetics , Gingival Neoplasms/enzymology , Gingival Neoplasms/genetics , Gingival Neoplasms/therapy , Head and Neck Neoplasms/genetics , Head and Neck Neoplasms/therapy , Humans , Oligonucleotides, Antisense/genetics , Probability , Protein Serine-Threonine Kinases/biosynthesis , Reference Values , Sensitivity and Specificity , Transfection , Tumor Cells, Cultured
13.
Semin Hematol ; 37(4 Suppl 7): 34-42, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11147488

ABSTRACT

Although exciting advances in monoclonal antibody therapy have already occurred, a review of agents in earlier stages of development reveals that many new agents may be approaching the clinic in the years to come. A look at the horizon of monoclonal antibody therapy reveals the following: novel strategies for augmenting the efficacy of monoclonal antibodies with which many clinicians are already familiar; novel antibodies with activity against lymphoma cells; novel technologies for generating and humanizing monoclonal antibodies; novel types of antibody-based therapeutics; and novel uses for these agents as modulators of the host immune system or other aspects of host-tumor interaction. Research in each of these areas will be reviewed.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Lymphoma/therapy , Alemtuzumab , Antibodies, Monoclonal, Humanized , Antibodies, Neoplasm/therapeutic use , Antigens, CD/immunology , Humans , Immune System Diseases/therapy , Lymphoma/drug therapy
14.
J Cell Biochem Suppl ; Suppl 35: 130-5, 2000.
Article in English | MEDLINE | ID: mdl-11389542

ABSTRACT

Many stimuli play a role in influencing the structure and function of chromatin and nuclear matrix through post-translational modifications of the component proteins in these dynamic structures. We propose that the protein serine/threonine kinase CK2 (formerly casein kinase II) is one such agent that is involved in signal transduction in the nuclear matrix and chromatin in response to a variety of stimuli. Protein kinase CK2 appears to undergo rapid modulations in its association with nuclear matrix and nucleosomes in response to mitogenic signals and is involved in the phosphorylation of a variety of intrinsic proteins in these structures depending on the state of genomic activity. In addition, its association or loss from the nuclear matrix may also influence the apoptotic activity in the cell. CK2 has been found to be dysregulated in virtually all the neoplasias examined and nuclear association appears to be an important facet of its expression in tumor cells. We hypothesize that CK2 provides a functional paradigm linking the nuclear matrix and chromatin structures. Identification of precise loci of action of CK2 in these structures and how they influence the morphological appearance of the nucleus under normal and abnormal growth conditions would be an important future direction of investigation. J. Cell. Biochem. Suppl. 35:130-135, 2000. Published 2001 Wiley-Liss, Inc.


Subject(s)
Cell Nucleus/metabolism , Neoplasms/metabolism , Protein Serine-Threonine Kinases/metabolism , Signal Transduction , Animals , Casein Kinase II , Cell Division , Humans , Tumor Cells, Cultured
15.
J Cell Biochem ; 74(1): 127-34, 1999 Jul 01.
Article in English | MEDLINE | ID: mdl-10381269

ABSTRACT

Modest dysregulation of CK2 has been shown to enhance the oncogenic potential in transgenic models of cancer. Since nuclear matrix serves as an anchor for CK2 and plays a key role in growth-related activities, we examined the effects of CK2 overexpression on its signaling to the nuclear matrix. Expression plasmids pCI-CK2alpha, pCI-CK2beta, and the bicistronic pCI-CK2alphabeta containing full length cDNAs encoding the various subunits were employed to transiently transfect two cell lines, BPH-1 and COS-1. Cytosol from transfected BPH-1 cells containing alpha or beta or alpha + beta or alphabeta showed a modest increase in CK2 activity by 26%, 1%, 20%, and 17%, respectively, over that in the controls transfected with pCI vector. However, the corresponding increase in CK2 activity in the NM fraction was 156%, 8%, 147%, and 152%, respectively. Immunoblot analysis of the CK2 in the NM accorded with these data. Similar results were obtained with COS-1 cells or other expression vectors. The results suggest that moderate overexpression of CK2 in the cells evokes a differential several-fold enhancement in NM associated CK2 relative to that in the cytosol. This process may have a bearing on the functional signaling of this kinase in relation to its possible role in oncogenesis.


Subject(s)
Nuclear Matrix/metabolism , Protein Serine-Threonine Kinases/metabolism , Androgen-Binding Protein/genetics , Animals , Blotting, Western , Casein Kinase II , Cell Line , Complement C3/genetics , Cytosol/enzymology , DNA, Complementary , Protein Serine-Threonine Kinases/genetics , Signal Transduction , Transfection
16.
Mol Cell Biochem ; 191(1-2): 135-42, 1999 Jan.
Article in English | MEDLINE | ID: mdl-10094402

ABSTRACT

Protein kinase CK2 undergoes rapid translocation to nuclear matrix and nucleosomes on androgenic stimulation of growth in prostatic epithelial cells. Further, CK2 appears to be regulated differentially in the transcriptionally active and inactive nucleosomes. We have investigated the role of CK2 in phosphorylation of nucleosome-associated proteins in the transcriptionally active and inactive nucleosomes that were isolated from ventral prostate subjected to different androgenic status in vivo. Proteins associated with these nucleosomes were phosphorylated via the intrinsic protein kinase activity, using [gamma-32P]ATP in the absence and presence of GTP. Several proteins appear to be potential substrates for CK2 associated with the nucleosomes. Among them are proteins that are differentially associated with the transcriptionally active and inactive nucleosomes. Phosphorylation of several of these proteins is modulated depending not only on their sites of association (i.e., active vs. inactive nucleosomes) but also on the state of transcriptional activity. Differential phosphorylation of specific proteins by CK2 associated with the active and inactive nucleosomes may be pertinent to the process of transcription regulation.


Subject(s)
Nucleosomes/metabolism , Protein Serine-Threonine Kinases/metabolism , Transcription, Genetic , Animals , Casein Kinase II , Male , Phosphorylation , Rats , Rats, Sprague-Dawley
17.
Cancer Res ; 59(5): 1146-51, 1999 Mar 01.
Article in English | MEDLINE | ID: mdl-10070976

ABSTRACT

Protein kinase CK2, a messenger-independent serine/threonine kinase, has been implicated in cell growth. Androgenic stimulus in rat prostate modulates its association with nuclear matrix (NM) and chromatin. Because the growth of human prostate carcinoma cells is influenced by androgens and/or growth factors, we determined the nature of CK2 signaling in the NM in response to androgen and growth factor stimuli. Androgen-sensitive LNCaP and androgen-insensitive PC-3 cells were cultured in media to regulate their growth in the presence of 5alpha-dihydrotestosterone (5alpha-DHT) or growth factors (epidermal growth factor, keratinocyte growth factor, and transforming growth factor alpha). The activity of CK2 was measured in the cytosolic and NM fractions isolated from these cells after treatment with growth stimuli. The changes in CK2 in various fractions were also confirmed by immunoblotting with a specific antibody. LNCaP cells responded to both 5alpha-DHT and growth factors for growth. The presence of these agents in the culture medium evoked a translocation of CK2 to the NM from the cytosol. The PC-3 cells did not respond to 5alpha-DHT for growth but did respond to growth factors. Under these conditions, there was also a translocation of CK2 to the NM concomitant with a decrease in the cytosolic fraction. These results suggest that CK2 translocation to the NM occurs in response to various growth stimuli in cells in culture. Thus, CK2 is a common downstream signal transducer in response to diverse growth stimuli that may relate to the pathobiology of prostate cancer cells.


Subject(s)
Dihydrotestosterone/pharmacology , Fibroblast Growth Factors , Growth Substances/pharmacology , Nuclear Matrix/physiology , Protein Serine-Threonine Kinases/metabolism , Signal Transduction/physiology , Adenocarcinoma , Animals , Casein Kinase II , Cell Division/drug effects , Chromatin/physiology , Cytosol/physiology , DNA-Binding Proteins/metabolism , Epidermal Growth Factor/pharmacology , Fibroblast Growth Factor 10 , Fibroblast Growth Factor 7 , Humans , Kinetics , Male , Prostatic Neoplasms , Rats , Signal Transduction/drug effects , Transforming Growth Factor alpha/pharmacology , Tumor Cells, Cultured
18.
J Cell Biochem ; 72(2): 242-50, 1999 Feb 01.
Article in English | MEDLINE | ID: mdl-10022506

ABSTRACT

Nuclear matrix (NM), a proteinaceous network of filaments, dictates nuclear morphology and the structure/function of DNA. Phosphorylation of NM proteins is a potential signal for regulating matrix functions. Histones also are intimately involved in DNA structure and transcription. Here, we report that various histones enhanced 32P incorporation into certain NM proteins. Modulation of NM protein phosphorylation by histones is mediated through regulation of protein kinase CK2, a messenger-independent serine/threonine kinase, which is significantly associated with the NM. The stimulatory effect of histones was mitigated by prior incubation of histones with DNA in the reaction. Phosphorylation of NM proteins was extensively reduced when an excess of the CK2-specific peptide substrate was included in the phosphorylation reaction as a competitor. Also, enhancement in the NM-associated CK2 activity by histones was blocked by inhibitors of CK2. Histone H1 effect appeared to be mediated mainly by charge effect since a stretch of polylysine induced a similar effect. Various histones also differentially affected the autophosphorylation of NM-associated CK2 subunits. This may contribute to the observed effects of histones on the NM, resulting in an enhancement and differential pattern of NM protein phosphorylation. Such a regional modification of NM protein phosphorylation might influence the nuclear functions that require histone displacement, namely, replication and transcription.


Subject(s)
Histones/pharmacology , Nuclear Proteins/metabolism , Protein Serine-Threonine Kinases/metabolism , Animals , Antigens, Nuclear , Casein Kinase II , Dose-Response Relationship, Drug , Male , Phosphorylation , Polylysine/pharmacology , Precipitin Tests , Rats , Rats, Sprague-Dawley
19.
Oral Oncol ; 35(3): 290-5, 1999 May.
Article in English | MEDLINE | ID: mdl-10621850

ABSTRACT

Overexpression of the epidermal growth factor (EGF) receptor, a hallmark of aerodigestive squamous cell carcinoma of the head and neck (SCCHN), correlates with aggressive tumor behavior. There is evidence that SCCHN cells auto-activate their EGF receptors. The receptor has therefore attracted interest as a potential therapeutic target. We tested the in vitro therapeutic efficacy of PD153035--a potent, specific inhibitor of the tyrosine kinase intrinsic to the EGF receptor--by employing a well-characterized cell line derived from human gingival SCCHN. DNA-synthesis and cell number were assayed for growth-inhibitory effects, phosphorylation of the EGF receptor was quantitated by immunoblot, and cell apoptosis was detected by terminal deoxytransferase (TdT)-mediated deoxyuridine triphosphate (dUTP)-biotin nick end labeling (TUNEL) in situ assay. PD153035, at nanomolar concentrations, inhibited autophosphorylation of the EGF receptor induced by EGF stimulation and the inhibition occurred in a dose-dependent manner. Under the same conditions, PD153035 inhibited cell growth, and induced apoptosis of SCCHN cells in vitro. We conclude that selective inhibition of the EGF receptor tyrosine kinase completely abolishes EGF receptor phosphorylation resulting from receptor stimulation, and results in growth inhibition and apoptosis of SCCHN cells in vitro. By inducing cytostasis and apoptosis, this new class of inhibitors may be of therapeutic value against SCCHN.


Subject(s)
Carcinoma, Squamous Cell/drug therapy , Enzyme Inhibitors/therapeutic use , ErbB Receptors/metabolism , Gingival Neoplasms/drug therapy , Quinazolines/therapeutic use , Apoptosis/drug effects , Carcinoma, Squamous Cell/enzymology , Carcinoma, Squamous Cell/pathology , Gingival Neoplasms/enzymology , Gingival Neoplasms/pathology , Humans , Tumor Cells, Cultured
20.
Int J Gynecol Pathol ; 17(4): 312-9, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9785131

ABSTRACT

The identification of prognostic variables is an important aspect of managing and counseling women with endometrial adenocarcinoma. The surgical stage, age, cell type, depth of myometrial invasion, and histologic grade have all been previously demonstrated to be related to prognosis. Several reports have indicated that tumor ploidy as determined by flow cytometry with fresh or fixed cells removed from paraffin blocks of endometrial adenocarcinomas can contribute to the assessment of prognosis. To verify the significance of DNA content in endometrial adenocarcinoma, we conducted an historical cohort study on a subgroup of women from a Gynecologic Oncology Group (GOG) protocol of early clinical stage disease. Flow cytometry was performed at one facility on cells extracted from blocks obtained from several GOG member institutions. Blocks were submitted for 293 of 933 eligible patients. Ninety-two histograms were of good quality, with 55 interpreted as diploid and 37 as aneuploid. One hundred sixty-two histograms were technically suboptimal, of which 137 were considered probably diploid, 13 probably aneuploid, and 12 unacceptable due to high background noise. Of the commonly accepted prognostic variables, only depth of invasion was significantly related to the ploidy status. There was no discernable difference in survival between patients with diploid and patients with probable diploid and probable aneuploid tumor types. Incorporation of the flow cytometry data into a proportional hazards regression model adjusted for age and surgical stage revealed a significant increased risk of disease-related death (relative risk, 4.1; 95% confidence interval, 2.3 to 7.3) for patients with aneuploid tumor type as compared to patients with diploid tumor type. This study confirms the prognostic significance of ploidy determination by flow cytometry and also indicates some of the difficulties of retrospectively applying this technology to cooperative group studies.


Subject(s)
Adenocarcinoma/genetics , DNA, Neoplasm/analysis , Endometrial Neoplasms/genetics , Adenocarcinoma/surgery , Aneuploidy , Cohort Studies , Diploidy , Endometrial Neoplasms/surgery , Female , Flow Cytometry , Humans , Neoplasm Invasiveness , Neoplasm Staging , Prognosis
SELECTION OF CITATIONS
SEARCH DETAIL
...